Trial Profile
Clinical Trials Insight: 700055551
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2010
Price :
$35
*
At a glance
- Drugs Nelitolimod (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- 21 Apr 2010 New trial record.
- 15 Apr 2010 Results were reported at the 45th Annual Meeting of the European Association for the Study of the Liver.